View in EDS HTML Full Text PDF Full Text

Effectiveness, Safety, and Health-Related Quality of Life in Moderate-to-Severe Atopic Dermatitis Treated with Lebrikizumab: A 16-Week Nationwide Retrospective Cohort Study.

Saved in:
Bibliographic Details
Title: Effectiveness, Safety, and Health-Related Quality of Life in Moderate-to-Severe Atopic Dermatitis Treated with Lebrikizumab: A 16-Week Nationwide Retrospective Cohort Study.
Authors: Avallone, Gianluca1,2 (AUTHOR) gianluca.avallone2@gmail.com, Bombelli, Andrea1,2 (AUTHOR), Gargiulo, Luigi3,4 (AUTHOR), Foti, Caterina5 (AUTHOR), Trave, Ilaria6 (AUTHOR), Rossi, Mariateresa7 (AUTHOR), Magnaterra, Elisabetta8,9 (AUTHOR), Pigliacelli, Flavia10 (AUTHOR), Malagoli, Piergiorgio11 (AUTHOR), Giacalone, Serena12 (AUTHOR), Portarapillo, Antonio13 (AUTHOR), Patruno, Cataldo14 (AUTHOR), Schettini, Natale15 (AUTHOR), Bonzano, Laura16 (AUTHOR), Pezzolo, Elena17 (AUTHOR), Chello, Camilla18 (AUTHOR), Gori, Niccolò19,20 (AUTHOR), Brunasso, Giovanna21 (AUTHOR), Veronese, Federica22 (AUTHOR), Ortoncelli, Michela23 (AUTHOR)
Source: Dermatology & Therapy. Dec2025, Vol. 15 Issue 12, p3671-3688. 18p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21938210
DOI:10.1007/s13555-025-01550-8